RxDoctor Payments Data

Johnnie Cook, MD

Family Medicine · Layton, UTNPI 1104934280

Payments from drug & device makers

$8,640in general payments, 2019–2025

Across 492 payments — averaging $17.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Lilly USA, LLC$639
  • GSK$559
  • Pfizer$541
  • Boehringer Ingelheim$511
  • AstraZeneca$457
  • plus $5K from 54 others

What the payments were for

  • Food & beverage$8,622100%
  • Education$180%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)62$1,037
Lilly USA, LLC49$639
GSK30$559
Pfizer48$541
Boehringer Ingelheim25$511
AstraZeneca23$457
Astellas Pharma US Inc25$437
Supernus Pharmaceuticals, Inc.4$321
Johnson & Johnson21$318
Amgen21$318
Amarin Pharma, Inc.20$269
Sanofi-aventis U.S. LLC11$263
Phathom Pharmaceuticals, Inc.8$197
E.r. Squibb & Sons, L.L.C.14$196
Abbott2$158
Merck10$155
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC7$132
Sunovion Pharmaceuticals Inc.3$131
Eisai Inc.2$111
Lucid Diagnostics Inc.3$108
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)6$107
Dynavax Technologies Corporation7$106
Tris Pharma Inc2$95
Inspire Medical Systems, Inc.5$90
Axsome Therapeutics, Inc.5$85
Biogen5$83
Daiichi Sankyo Inc.4$72
Dexcom, Inc.3$66
Sumitomo Pharma America, Inc.4$66
Biohaven Pharmaceutical Holding Company Ltd.3$64
Exact Sciences4$59
Biohaven Pharmaceuticals, Inc.4$58
Cranial Technologies, Inc3$52
Shire North American Group Inc4$50
Takeda Pharmaceuticals U.S.A., Inc.3$45
Idorsia Pharmaceuticals US Inc3$45
Novo Nordisk3$43
Novartis3$43
Mylan Specialty L.p.2$43
Genentech USA, Inc.3$43
Mayne Pharma Commercial LLC1$38
Organon3$35
Neurocrine Biosciences, Inc.2$32
Adlon Therapeutics L.p.2$31
Innovation Technologies Inc1$30
Alkermes, Inc.2$27
Viatris Specialty LLC1$26
Edwards Lifesciences1$23
Ultragenyx Pharmaceutical Inc.1$21
BD1$17
Almatica Pharma LLC1$17
Shield Therapeutics Inc1$16
Jazz Pharmaceuticals Inc.1$16
BETA Bionics, Inc.1$15
Seqirus USA Inc1$15
Bayer1$15
Avanir Pharmaceuticals, Inc.1$14
Sanofi Pasteur Inc.1$14
Ironshore Pharmaceuticals Inc.1$14
Neurelis, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,640 in reported general payments places this provider in the 90th percentile of 928 family medicine providers in Utah.

See all family medicine providers in Utah

Medicare billing

Part B allowed, 2024
$148,508
Medicare patients
239
Services billed
5,127

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide61$64,421
XareltoRivaroxaban36$56,298
EliquisApixaban53$55,012
JardianceEmpagliflozin25$41,432
XifaxanRifaximin12$39,412
MounjaroTirzepatide28$38,182
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog23$34,188
TrulicityDulaglutide20$31,806
MyrbetriqMirabegron19$15,247
VyvanseLisdexamfetamine Dimesylate21$8,007
Omeprazole257$4,912
Levothyroxine Sodium316$4,635
Lansoprazole21$4,476
Atorvastatin Calcium311$4,233
Celecoxib113$3,659

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$639$69,98848 claims
Novo NordiskOzempic$43$64,42161 claims
Johnson & JohnsonXarelto$318$56,29836 claims
PfizerEliquis$541$55,01253 claims
Boehringer IngelheimJardiance$511$41,43225 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$132$39,41212 claims
Astellas Pharma US IncMyrbetriq$437$15,24719 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$45$8,00721 claims
Almatica Pharma LLCSertraline Hcl$17$1,488111 claims
AbbVieSynthroid$1,037$1,32518 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 928 family medicine providers in Utah.

Other family medicine in Layton

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →